OverviewChartNewsTraderScreen

BIOTEST AG ST O.N./  DE0005227201  /

Xetra
3/31/2023  5:36:01 PM Chg. +0.300 Volume Bid3/31/2023 Ask3/31/2023 High Low
42.500EUR +0.71% 0
Turnover: 0.000		 -Bid Size: - -Ask Size: - 42.500 42.500
GlobeNewswire 12/3/2021 Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congres...
GlobeNewswire 8/9/2021 ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA...
GlobeNewswire 4/13/2021 ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Inf...
GlobeNewswire 12/9/2020 ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
GlobeNewswire 3/3/2020 AB2 Bio Appoints Michael Soldan CEO
GlobeNewswire 10/10/2019 2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Vo...
GlobeNewswire 10/10/2019 Canada Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strat...
GlobeNewswire 10/10/2019 United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Suppli...
GlobeNewswire 10/10/2019 Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Gen...
GlobeNewswire 10/10/2019 Cyprus Nucleic Acid Testing Market for 100 Assays, 2019: Companies Such as Arca Biopharma, Diadexus ...
GlobeNewswire 10/10/2019 South Korean Nucleic Acid Testing Market for 100 Assays: Five-year test volume and sales forecasts
GlobeNewswire 10/10/2019 2019 Kuwait Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volu...
GlobeNewswire 10/10/2019 Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic ...
GlobeNewswire 9/23/2019 ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference
GlobeNewswire 8/22/2019 ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
GlobeNewswire 8/8/2019 ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results
GlobeNewswire 7/8/2019 ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
GlobeNewswire 6/18/2019 Global $12.89 Bn Glucose Monitoring Markets, 2018-2019 & 2019-2025
GlobeNewswire 5/29/2019 ADMA Biologics to Present at Upcoming Investor Conferences
GlobeNewswire 5/10/2019 FDA Approves Prior Approval Supplement for BIVIGAM®
GlobeNewswire 5/8/2019 ADMA Biologics Reports First Quarter 2019 Financial Results
GlobeNewswire 5/3/2019 ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credi...
GlobeNewswire 5/2/2019 2019 Nucleic Acid Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers
GlobeNewswire 4/25/2019 United States Infectious Disease Molecular Diagnostics Markets 2019-2024 - Strategic Assessments of ...
GlobeNewswire 4/11/2019 Immunoglobulins Market to Touch US$ 20,757.1 Mn by 2026, Advancements in Research and Development of...